Omalizumab—A Review

Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.

Detalles Bibliográficos
Autores principales: Godse, Kiran, Mehta, Aayushi, Patil, Sharmila, Gautam, Manjyot, Nadkarni, Nitin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Residents' Page
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533538/
https://www.ncbi.nlm.nih.gov/pubmed/26288408
http://dx.doi.org/10.4103/0019-5154.160490
_version_ 1782385353644048384
author Godse, Kiran
Mehta, Aayushi
Patil, Sharmila
Gautam, Manjyot
Nadkarni, Nitin
author_facet Godse, Kiran
Mehta, Aayushi
Patil, Sharmila
Gautam, Manjyot
Nadkarni, Nitin
author_sort Godse, Kiran
collection PubMed
description Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.
format Online
Article
Text
id pubmed-4533538
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-45335382015-08-18 Omalizumab—A Review Godse, Kiran Mehta, Aayushi Patil, Sharmila Gautam, Manjyot Nadkarni, Nitin Indian J Dermatol Residents' Page Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4533538/ /pubmed/26288408 http://dx.doi.org/10.4103/0019-5154.160490 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Residents' Page
Godse, Kiran
Mehta, Aayushi
Patil, Sharmila
Gautam, Manjyot
Nadkarni, Nitin
Omalizumab—A Review
title Omalizumab—A Review
title_full Omalizumab—A Review
title_fullStr Omalizumab—A Review
title_full_unstemmed Omalizumab—A Review
title_short Omalizumab—A Review
title_sort omalizumab—a review
topic Residents' Page
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533538/
https://www.ncbi.nlm.nih.gov/pubmed/26288408
http://dx.doi.org/10.4103/0019-5154.160490
work_keys_str_mv AT godsekiran omalizumabareview
AT mehtaaayushi omalizumabareview
AT patilsharmila omalizumabareview
AT gautammanjyot omalizumabareview
AT nadkarninitin omalizumabareview

Ejemplares similares